Market Research Logo

Europe Glaucoma Epidemiology and Patient Flow Analysis - 2017

Europe Glaucoma Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Glaucoma patients study in a new report ‘Europe Glaucoma Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucoma treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Glaucoma derived from epidemiological analysis, percentage of patients diagnosed with Glaucoma, and percentage of patients treated with a therapy.

The study helps executives estimate Glaucoma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Glaucoma prevalence, Glaucoma diagnosis rate, and Glaucoma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Glaucoma Patient Flow
  • Glaucoma Prevalence
  • Glaucoma Diagnosed Patients
  • Glaucoma Treated Patients


1. Glaucoma: Disease Definition
2. Glaucoma Patient Flow in Europe
2A. Glaucoma Prevalence in Europe
2B. Glaucoma Diagnosed Patients in Europe
2C. Glaucoma Treated Patients in Europe
3. Glaucoma Patient Flow in Germany
3A. Glaucoma Prevalence in Germany
3B. Glaucoma Diagnosed Patients in Germany
3C. Glaucoma Treated Patients in Germany
4. Glaucoma Patient Flow in France
4A. Glaucoma Prevalence in France
4B. Glaucoma Diagnosed Patients in France
4C. Glaucoma Treated Patients in France
5. Glaucoma Patient Flow in Spain
5A. Glaucoma Prevalence in Spain
5B. Glaucoma Diagnosed Patients in Spain
5C. Glaucoma Treated Patients in Spain
6. Glaucoma Patient Flow in Italy
6A. Glaucoma Prevalence in Italy
6B. Glaucoma Diagnosed Patients in Italy
6C. Glaucoma Treated Patients in Italy
7. Glaucoma Patient Flow in UK
7A. Glaucoma Prevalence in UK
7B. Glaucoma Diagnosed Patients in UK
7C. Glaucoma Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Glaucoma Patient Flow in Europe, 2016
Table 2: Glaucoma Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Glaucoma Patient Flow in Germany, 2016
Table 4: Glaucoma Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Glaucoma Patient Flow in France, 2016
Table 6: Glaucoma Patient Flow Forecast in France, 2016 - 2025
Table 7: Glaucoma Patient Flow in Spain, 2016
Table 8: Glaucoma Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Glaucoma Patient Flow in Italy, 2016
Table 10: Glaucoma Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Glaucoma Patient Flow in UK, 2016
Table 12: Glaucoma Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Glaucoma Patient Flow in Europe, 2016
Figure 2: Glaucoma Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Glaucoma Patient Flow in Germany, 2016
Figure 4: Glaucoma Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Glaucoma Patient Flow in France, 2016
Figure 6: Glaucoma Patient Flow Forecast in France, 2016 - 2025
Figure 7: Glaucoma Patient Flow in Spain, 2016
Figure 8: Glaucoma Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Glaucoma Patient Flow in Italy, 2016
Figure 10: Glaucoma Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Glaucoma Patient Flow in UK, 2016
Figure 12: Glaucoma Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report